One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Scientists have developed two new imaging agents that work better than the only currently approved one for detecting tau ...

Whether you're curious to explore a healthy brain or brains affected by Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, or Frontotemporal dementia, the choice is yours. Tailoring ...

Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...

President Donald Trump signed the bipartisan Laken Riley Act into law as his administration’s first piece of legislation.

Two clinical trials of dementia care programs report negative results in terms of patient neuropsychiatric symptoms and ...

Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

Watching an older loved one's mind fade is often a slow, challenging experience for everyone involved. However, sometimes the memory loss can happen fast, leaving little time for answers.

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...